Effects of Antidepressants on Sexual Functioning

Completed · Phase 3

Conditions studied: Major Depressive Disorder (MDD)

In brief

The purpose of this trial is to study the effects of two depression medications on sexual functioning.

Key facts

Study ID

NCT00051259

Run by

GlaxoSmithKline

People needed

420

Starts

2003-01-01

Expected to finish

2004-06-01

Last updated by the study team

2010-10-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary diagnosis of Major Depressive Disorder (MDD) with current duration lasting 12 weeks but no greater than 2 years.
• Subjects must engage in sexual activity that leads to orgasm at least once every two weeks.
• Subject must have normal orgasmic function and be willing to discuss with investigator.

You may not qualify if…

• Subjects that have arousal or orgasm dysfunction.
• Has previously failed to respond to two adequate trials of antidepressants in past 2 years.
• Subject has other unstable medical disorders.
• Subject has a positive urine test for illicit drug use at screening.

Where it is running

• GSK Investigational Site — Berkeley, California, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — La Mesa, California, United States
• GSK Investigational Site — Oceanside, California, United States
• GSK Investigational Site — Coral Springs, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Terre Haute, Indiana, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Minneapolis, Minnesota, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Toledo, Ohio, United States
• GSK Investigational Site — Tulsa, Oklahoma, United States
• GSK Investigational Site — Eugene, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Lincoln, Rhode Island, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Bellaire, Texas, United States
• GSK Investigational Site — Charlottesville, Virginia, United States
• GSK Investigational Site — Richmond, Virginia, United States
• GSK Investigational Site — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.